Agnew Brianna, Couture Marie-Claude, Uwimana Honorine, Callaghan Timothy, Olsanksa Elizabeth Jitka, Arah Onyebuchi A, Baker Jillian, Regan Annette K
School of Nursing and Health Professions, University of San Francisco, San Francisco, California.
Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts.
J Adolesc Health. 2025 Apr;76(4):542-557. doi: 10.1016/j.jadohealth.2024.10.027. Epub 2025 Jan 30.
Although COVID-19 vaccination is recommended for adolescents aged 12-17 years, they remain one of the least commonly vaccinated age groups. Therefore, studies investigating the factors associated with vaccine hesitancy among adolescents are needed. We conducted a systematic review of the literature in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards from inception to October 23, 2022, for adolescent-reported factors associated with vaccine hesitancy. Titles and abstracts of articles were screened, full-text articles were reviewed for eligibility, and eligible articles were extracted by 2 independent reviewers. Results were summarized using a narrative synthesis. The review protocol was prospectively registered in PROSPERO (CRD42022363411). Of 4,140 articles screened, 302 were selected for full-text review, 27 of which met the eligibility criteria. Most studies evaluated age (n = 20 studies) and sex (n = 21 studies) in relation to COVID-19 vaccine hesitancy, yet these were uncommonly linked with vaccine hesitancy among adolescents. Adolescents consistently reported the impact of the pandemic on social activities, social and parental norms, and a sense of communal responsibility as reasons for vaccinating. Although fewer studies (n = 18 studies) evaluated theoretical-based factors, the studies conducted showed that perceived vaccine safety and efficacy (n = 6 studies), risks from vaccination (n = 5 studies), and social and parental norms (n = 3) were consistently linked with vaccine hesitancy. To address low vaccination rates, adolescent-engaged research remains needed that considers their perspectives on COVID-19 vaccines.
尽管建议12至17岁的青少年接种新冠疫苗,但他们仍然是接种率最低的年龄组之一。因此,需要开展研究来调查与青少年疫苗犹豫相关的因素。我们按照系统评价和Meta分析的首选报告项目标准,对从开始到2022年10月23日的文献进行了系统回顾,以查找青少年报告的与疫苗犹豫相关的因素。对文章的标题和摘要进行筛选,对全文进行资格审查,由两名独立评审员提取符合条件的文章。结果采用叙述性综合法进行总结。该综述方案已在国际前瞻性系统评价注册库(PROSPERO,注册号:CRD42022363411)中预先注册。在筛选的4140篇文章中,有302篇被选作全文评审,其中27篇符合资格标准。大多数研究评估了年龄(20项研究)和性别(21项研究)与新冠疫苗犹豫的关系,但这些因素在青少年中与疫苗犹豫的关联并不常见。青少年一致报告称,疫情对社交活动、社会和父母规范以及社区责任感的影响是他们接种疫苗的原因。虽然较少有研究(18项研究)评估基于理论的因素,但已开展的研究表明,对疫苗安全性和有效性的认知(6项研究)、接种疫苗的风险(5项研究)以及社会和父母规范(3项研究)一直与疫苗犹豫有关。为了解决低接种率问题,仍需要开展以青少年为参与对象的研究,考虑他们对新冠疫苗的看法。